Trend toward noninferiority trials may mean more difficult interpretation of trial results.
Tuma
Rabiya S
RS
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000379:methods* / Q000592:standards; D003627:Data Interpretation, Statistical; D017277:Drug Approval; D004345:Drug Industry; D006801:Humans; D008389:Marketing of Health Services / Q000592:standards; D009369:Neoplasms / Q000188:drug therapy*; D010349:Patient Compliance; D012107:Research Design; D016896:Treatment Outcome
D000970:Antineoplastic Agents